Vir Biotechnology, Inc. Form 4 (Dec. 22, 2022)

Summary

This Form 4, filed by SVF Endurance (Cayman) Limited with SoftBank Vision Fund (AIV M1) L.P. and SB Investment Advisers (UK) Limited, reports Rule 10b5-1 trading plan sales of Vir Biotechnology, Inc. (VIR) common stock. On 12/22/2022, 22,801 shares sold at a weighted average price of $25.8718 and 72,343 shares at $26.1324. On 12/23/2022, 79,760 shares sold at $25.7616 and 321 shares at $26.0737. The shares reported as indirect totaled 20,310,554 afterward. Signatures by Rhonda Gornitsky and Amanda Sanchez-Barry are dated 12/27/2022.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * SVF Endurance (Cayman) Ltd (Last) (First) (Middle) C/O WALKERS CORP LTD., 190 ELGIN AVENUE (Street) GEORGE TOWN E9 KY1-9008 (City) (State) (Zip) | SVF Endurance (Cayman) Ltd | (Last) | (First) | (Middle) | C/O WALKERS CORP LTD., 190 ELGIN AVENUE | GEORGE TOWN | E9 | KY1-9008 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Vir Biotechnology, Inc. [ VIR ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below) | Director | X | 10% Owner | Officer (give title below) | Other (specify below)
3. Date of Earliest Transaction
 (Month/Day/Year) 12/22/2022
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person | Form filed by One Reporting Person | X | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 12/22/2022 | S (1) | 22,801 | D | $ 25.8718 (2) | 20,462,978 | I | See footnote (3)
Common Stock | 12/22/2022 | S (1) | 72,343 | D | $ 26.1324 (4) | 20,390,635 | I | See footnote (3)
Common Stock | 12/23/2022 | S (1) | 79,760 | D | $ 25.7616 (5) | 20,310,875 | I | See footnote (3)
Common Stock | 12/23/2022 | S (1) | 321 | D | $ 26.0737 (6) | 20,310,554 | I | See footnote (3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
1. Name and Address of Reporting Person * SVF Endurance (Cayman) Ltd (Last) (First) (Middle) C/O WALKERS CORP LTD., 190 ELGIN AVENUE (Street) GEORGE TOWN E9 KY1-9008 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below) | SVF Endurance (Cayman) Ltd | (Last) | (First) | (Middle) | C/O WALKERS CORP LTD., 190 ELGIN AVENUE | GEORGE TOWN | E9 | KY1-9008 | (City) | (State) | (Zip) | Director | X | 10% Owner | Officer (give title below) | Other (specify below)
1. Name and Address of Reporting Person * SB INVESTMENT ADVISERS (UK) LTD (Last) (First) (Middle) 69 GROSVENOR STREET (Street) LONDON X0 W1K 3JP (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below) | SB INVESTMENT ADVISERS (UK) LTD | (Last) | (First) | (Middle) | 69 GROSVENOR STREET | LONDON | X0 | W1K 3JP | (City) | (State) | (Zip) | Director | X | 10% Owner | Officer (give title below) | Other (specify below)
1. Name and Address of Reporting Person * SOFTBANK VISION FUND (AIV M1) L.P. (Last) (First) (Middle) 251 LITTLE FALLS DRIVE (Street) WILMINGTON DE 19808 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below) | SOFTBANK VISION FUND (AIV M1) L.P. | (Last) | (First) | (Middle) | 251 LITTLE FALLS DRIVE | WILMINGTON | DE | 19808 | (City) | (State) | (Zip) | Director | X | 10% Owner | Officer (give title below) | Other (specify below)
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.75 to $25.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. ("SVF"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.21. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.57 to $25.9967. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.0069 to $26.1084. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
SVF Endurance (Cayman) Limited, By: /s/ Rhonda Gornitsky, Director | 12/27/2022
SoftBank Vision Fund (AIV M1) L.P., By: SB Investment Advisers (UK) Limited, its manager, By: /s/ Amanda Sanchez-Barry, General Counsel | 12/27/2022
SB Investment Advisers (UK) Limited, By: /s/ Amanda Sanchez-Barry, General Counsel | 12/27/2022
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_VIR_4_filed2022-12-27_0000899243-22-039418.xml

Size

26,815 bytes

SHA-256

df7ce82d012265875c320dcdfb19e31060d49563d85fd1dacf5d5867e8a787f4

Our copy

SEC_VIR_4_filed2022-12-27_0000899243-22-039418.xml

Original

www.sec.gov